Maria Ioannou
@mariaioannou_md
Postdoctoral research fellow @hopkinskimmel studying #glioblastoma and #NF1 |M.D. from 🇬🇷
ID: 2555257142
08-06-2014 18:13:57
85 Tweet
224 Followers
619 Following
We are so grateful for the support of #CannonballKidsCancer for research in the lab of Hopkins early career sarcoma physician scientist Katie Lemberg, MD, PhD for her research in metabolic inhibitors in soft tissue sarcomas. congratulations 🎉 Dr Lemberg! Johns Hopkins Kimmel Cancer Center Johns Hopkins Children's Center
Incredible honored and elated to be joining the amazing family of The Osler Medical Residency JHU PSP!!! Immensely grateful to my wonderful mentors and friends, Thorsten Leucker, Gary Gerstenblith, Steven Schulman, Allison G. Hays, MD, Tarek Harb, Michael A. Vavuranakis, and so many more Johns Hopkins Cardiology
Learn more about 2023 CCF Giant Food NextGen Awardee Johns Hopkins Kimmel Cancer Center Yiouli Ktena, M.D. and her research on bone marrow transplants for pediatric blood cancer. childrenscancerfoundation.org/yiouli-ktena-m… Proposals due 5/5 for 2024 Grants: bit.ly/ccfgrantapplic… #CancerResearch #childhoodcancer
In ASCO’s Daily News our NCI CCR Pediatric Oncology Branch-Test Account -Mayo Clinic #collaboration discuss the transformative potential for #cfDNA #liquidbx in hereditary cancer syndrome surveillance. We highlight strives by Dan Landau, Pugh Lab and others towards this 🥅 dailynews.ascopubs.org/do/understandi…
Thrilled to see our work on how MEK inhibition enhances the anti-tumor effect of radiation therapy in GBM, published in Molecular Cancer Therapeutics. Special thanks to Dr. Schreck, Christine Pratilas MD, Abiola for their support and guidance! #NF1 #GBM #cureGBM 🧠
I learned so much from this ASCO project with Martin van den Bent and Dr. Mellinghoff Memorial Sloan Kettering Cancer Center. Thank you Lauren Schaff, MD Marjolein Geurts and Maria Ioannou! ascopubs.org/doi/10.1200/ED…
Happy to share our latest work with Dr. Schreck on State of the Art in Low-Grade Glioma Management: Insights From Isocitrate Dehydrogenase and Beyond | that you can read about on American Society of Clinical Oncology Educational Book ascopubs.org/doi/10.1200/ED…
#NFAwareness month at the Johns Hopkins Medicine dome tonight and all month! So thankful for the work so many brilliant people are doing here to #cureNF Johns Hopkins Kimmel Cancer Center Neurofibromatosis Therapeutic Acceleration Program
Excited to share our labs research on targeted therapy for MPNST (Ava Wang); characterization of the immune microenvironment Lindy Zhang, MD PhD ; and the JH NF Biospecimen repository Stavriani Makri, MD at the NF conf in Brussels #NFcon24 #EndNF Children's Tumor Fdn Neurofibromatosis Therapeutic Acceleration Program Johns Hopkins Kimmel Cancer Center
Intra-individual variability in #Lipoproteina : the value of a repeat measure for reclassifying individuals at intermediate risk released at #ESCCongress and just published in #EHJOpen👉 bit.ly/3z3hHJE EHJOpen Editor-in-Chief Tarek Harb Efthymios (Timos) Ziogos Thorsten Leucker
New in Small Molecule Therapeutics from the September issue—MEK Inhibition Enhances the Antitumor Effect of #Radiotherapy in #NF1-Deficient #Glioblastoma. bit.ly/3XmdHMf Maria Ioannou Dr. Schreck Abiola Christine Pratilas MD Johns Hopkins Kimmel Cancer Center Johns Hopkins Neurosurgery
Wonderful collaboration with CJ Lucas, MD and the Neuro-Onc Precision Medicine Group Johns Hopkins Kimmel Cancer Center to understand the effect of NF1 loss on sporadic #GBM co-muts and survival. Johns Hopkins Neuro-Oncology Surgical Outcomes Lab Jordina Rincon-Torroella Fausto Rodriguez Maria Ioannou actaneurocomms.biomedcentral.com/articles/10.11…
Chen et al @HopkinsNSsurg, Johns Hopkins Neurology Residency, Johns Hopkins Pathology demonstrated Gliosarcoma has a similar overall survival but worse response to treatment and different mutational profile than glioblastoma. #JNO Read More: link.springer.com/article/10.100…